First Trust NYSE Arca Biotechnology Index Fund
FBT
222 hedge funds and large institutions have $1.77B invested in First Trust NYSE Arca Biotechnology Index Fund in 2019 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 56 reducing their positions, and 32 closing their positions.
89% more call options, than puts
Call options by funds: $2.37M | Put options by funds: $1.25M
64% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 56
6% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 32
0.47% more ownership
Funds ownership: 60% → 60.47% (+0.47%)
2% less funds holding
Funds holding: 227 → 222 (-5)
5% less capital invested
Capital invested by funds: $1.86B → $1.77B (-$93.3M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$62M |
| 2 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$14M |
| 3 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$6.69M |
| 4 |
Goldman Sachs
New York
|
+$5.49M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
-$24.7M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$20.8M |
| 3 |
Morgan Stanley
New York
|
-$20.2M |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
-$19.2M |
| 5 |
GA
Gateway Advisory
Westfield,
New Jersey
|
-$7.49M |
FBT Hedge Fund Activity: Q2 2019 in Review
222 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2019, worth a combined $1.77B — down 5% from $1.86B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new FBT positions and 32 closed out — a net gain of 2 holders — while 92 added to existing stakes and 56 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $62M. The largest seller was Fulcrum Equity Management, exiting entirely with an estimated $24.7M sold.
- 222 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2019, down from 227 in Q1 2019.
- Funds reported $1.77B of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2019, down 5% quarter-over-quarter.
- 34 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2019 and 32 closed out, a net change of +2 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2019 was First Trust Advisors, an estimated $62M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2019 was Fulcrum Equity Management, an estimated $24.7M sold.
Based on aggregated 13F filings for Q2 2019.